Jubilant Pharmova has reported results for first quarter ended June 30, 2023 (Q1FY24).
The company has reported net profit at Rs 1.90 crore for the quarter under review as compared to net loss of Rs 5.20 crore for the same quarter in the previous year. Total income of the company increased by 8.61% at Rs 233.30 crore for Q1FY24 as compared Rs 214.80 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 87.18% fall in its net profit at Rs 6.00 crore for the quarter ended June 30, 2023 as compared to Rs 46.80 crore for the same quarter in the previous year. However, total income of the company increased by 9.06% at Rs 1595.50 crore for Q1FY24 as compared Rs 1463.00 crore for the corresponding quarter previous year.
